Cantex Pharmaceuticals, Inc.: CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT

Press Release: Cantex Pharmaceuticals, Inc. : CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE

Cantex Pharmaceuticals, Inc.: CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

Cantex Pharmaceuticals, Inc.: Allegheny Health Network site of study for pancreatic cancer treatment

Cantex Pharmaceuticals, Inc.: Cantex Pharmaceuticals Announces Article Published in npj Breast Cancer Highlighting Potential Role of RAGE Inhibition to Prevent Metastasis in Triple-Negative Breast Cancer

Cantex Pharmaceuticals, Inc.: vTv Therapeutics Partner Cantex Pharmaceuticals Licenses

Cantex Pharmaceuticals, Inc.: CANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY INVESTOR CONFERENCE IN BOSTON